K A Guthrie1, N R Tishkevich, J L Nelson. 1. Clinical Statistics D5-360, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. kguthrie@fhcrc.org
Abstract
OBJECTIVES: Some patients with rheumatoid arthritis (RA) lack RA-associated human leukocyte antigen (HLA) alleles. Prior studies investigated non-inherited maternal HLA alleles (NIMA) in RA risk with conflicting results. METHODS: We examined NIMA in a large cohort of families from the North American Rheumatoid Arthritis Consortium (NARAC). RESULTS: Among 620 patients with 1 or both parents having a HLA genotype, patients with RA informative for analysis included 176 without HLA-DRB1*04 and 86 without the HLA shared epitope (SE). The frequency of NIMA encoding HLA-DR4 or the SE was compared to the non-inherited paternal allele (NIPA). DR4-encoding NIMA vs NIPA revealed no significant difference (27% vs 20%). However, parity is known to modulate RA risk and analyses stratified by sex and age of onset showed significant variation among women. Interestingly, among women with onset <45 years DR4-encoding NIMA was increased compared to NIPA; among women > or =45 years at onset the reverse was observed (31% vs 16% compared to 10% vs 60%, p = 0.008). DR4 encoding NIMA vs NIPA did not differ in men. The SE did not differ in men or women. CONCLUSIONS: Risk of RA was associated with HLA-DR4 encoding NIMA in younger-onset women but not in older-onset women or men. These observations could help explain conflicting prior results of NIMA in RA.
OBJECTIVES: Some patients with rheumatoid arthritis (RA) lack RA-associated human leukocyte antigen (HLA) alleles. Prior studies investigated non-inherited maternal HLA alleles (NIMA) in RA risk with conflicting results. METHODS: We examined NIMA in a large cohort of families from the North American Rheumatoid Arthritis Consortium (NARAC). RESULTS: Among 620 patients with 1 or both parents having a HLA genotype, patients with RA informative for analysis included 176 without HLA-DRB1*04 and 86 without the HLA shared epitope (SE). The frequency of NIMA encoding HLA-DR4 or the SE was compared to the non-inherited paternal allele (NIPA). DR4-encoding NIMA vs NIPA revealed no significant difference (27% vs 20%). However, parity is known to modulate RA risk and analyses stratified by sex and age of onset showed significant variation among women. Interestingly, among women with onset <45 years DR4-encoding NIMA was increased compared to NIPA; among women > or =45 years at onset the reverse was observed (31% vs 16% compared to 10% vs 60%, p = 0.008). DR4 encoding NIMA vs NIPA did not differ in men. The SE did not differ in men or women. CONCLUSIONS: Risk of RA was associated with HLA-DR4 encoding NIMA in younger-onset women but not in older-onset women or men. These observations could help explain conflicting prior results of NIMA in RA.
Authors: S ten Wolde; F C Breedveld; R R de Vries; J D'Amaro; P Rubenstein; G M Schreuder; F H Claas; J J van Rood Journal: Lancet Date: 1993-01-23 Impact factor: 79.321
Authors: A J Silman; E M Hay; J Worthington; W Thomson; L Pepper; J Davidson; P A Dyer; W E Ollier Journal: Ann Rheum Dis Date: 1995-04 Impact factor: 19.103
Authors: I E van der Horst-Bruinsma; J M Hazes; G M Schreuder; T R Radstake; P Barrera; L B van de Putte; D Mustamu; D van Schaardenburg; F C Breedveld; R R de Vries Journal: Ann Rheum Dis Date: 1998-11 Impact factor: 19.103
Authors: Nathalie C Lambert; Timothy D Erickson; Zhen Yan; Jennifer M Pang; Katherine A Guthrie; Daniel E Furst; J Lee Nelson Journal: Arthritis Rheum Date: 2004-03
Authors: Hilary S Gammill; Katherine A Guthrie; Tessa M Aydelotte; Kristina M Adams Waldorf; J Lee Nelson Journal: Blood Date: 2010-07-13 Impact factor: 22.113
Authors: Paola G Bronson; Leanne K Komorowski; Patricia P Ramsay; Suzanne L May; Janelle Noble; Julie A Lane; Glenys Thomson; Frans H Claas; Michael F Seldin; Jennifer A Kelly; John B Harley; Kathy L Moser; Patrick M Gaffney; Timothy Behrens; Lindsey A Criswell; Lisa F Barcellos Journal: Arthritis Rheum Date: 2010-06